Emcure Pharmaceuticals and Sanofi India have entered in a partnership to distribute and promote Sanofi’s oral anti-diabetic drugs, including Amaryl and Cetapin, across India. The collaboration aims to expand access to trusted diabetes therapies through Emcure’s strong national network.
